Skip to content
  • Sunday, 26 July 2026
  • 1:44 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AI and Machine Learning Poised to Revolutionize Antibody Therapeutics, Experts Declare as Landmark Journal Collection Concludes
Biotech & Genetic Research

AI and Machine Learning Poised to Revolutionize Antibody Therapeutics, Experts Declare as Landmark Journal Collection Concludes

Jia Lissa Jul 23, 2026 0

The landscape of antibody therapeutic development is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI)…

Read More
Biotech & Genetic Research

Comprehensive Infographic Illuminates Advances in Spatial Data Collection: Comparing Imaging, Capture, and Novel Donation-Based Sequencing Techniques

Jia Lissa May 8, 2026 0

The landscape of biological research is undergoing a profound transformation, driven by an increasing demand to understand molecular processes within…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million to Revolutionize Blood Collection with Autonomous Robotic Phlebotomy, Poised for Global Expansion

Reynand Amr Wu Mar 22, 2026 0

Vitestro, a pioneering Dutch medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million Series B Funding to Revolutionize Blood Collection with Autonomous Robotics

Reynand Amr Wu Mar 14, 2026 0

Vitestro, a pioneering Dutch medical technology firm, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
How CTF is trying to rescue pharma’s shelved rare disease drugsThe developing brain is built through controlled DNA damage and rapid repair.Snail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and BeyondA ‘Super El Niño’ may be on the way. What does that mean?
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ